Insiders Sell Big as Data Lags Behind

The most striking open-market insider transaction in the latest available data is the ROBOTIS CEO Kim Byeong Soo, who sold 366,525 shares in the South Korean robotics firm for approximately $75 million on September 8. The trade was filed the same day, making it one of the largest C-level discretionary sales in the dataset.

In India, GLAND Pharma's promoter group entity Fosun Pharma Industrial sold two tranches totalling over $296 million worth of shares in early September. Fosun trimmed its stake twice within days, with trades of $228 million and $68 million filed on September 8. For context, ORTEX alt-data shows India recorded just 85,038 new car registrations in October 2026, the smallest October on record since 2017. That broader demand weakness adds pressure to the Indian equity story where promoter confidence appears to be fading.

Meanwhile JPMorgan Chase appeared across multiple Asian names as a 5%-owner filer, selling positions in Kingdee International and Sunny Optical, and buying into Huaneng Power, suggesting portfolio rebalancing rather than conviction trades.

On the activist front and index radar, the EDGAR 13D tables and first-party SEC Form 4 filings were not accessible via the available SQL environment, limiting the ability to surface fresh US open-market trades or confirmed activist crossings. The vendor insider dataset, used here for non-US markets only, runs to September 8, 2026. Trades filed after that date could not be retrieved.

The most actionable signal in the data remains the Fosun exit from GLAND Pharma: a promoter selling at scale, in multiple tranches, into a weakening Indian consumer backdrop is a pattern worth watching.